Results 201 to 210 of about 36,016 (212)

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

Lancet, The, 2001
Y Benhamou, Vincent Thibault, V Calvez   +2 more
exaly  

Lamivudine.

2011
openaire   +1 more source

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Monika van Zonneveld, Ulus S Akarca   +2 more
exaly  

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up

Journal of Hepatology, 2008
Hiromi Yatsuji, Tetsuya Hosaka, Sachiyo Watahiki   +2 more
exaly  

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

Journal of Hepatology, 2001
Alfredo Marzano, Mauro Salizzoni, Antonina Smedile   +2 more
exaly  

Lamivudine

Reactions Weekly, 2009
openaire   +2 more sources

Transdermal penetration of zalcitabine, lamivudine and synthesised N-acyl lamivudine esters

International Journal of Pharmaceutics, 2008
Minja Gerber, Jaco C Breytenbach, Jeanetta Du Plessis   +2 more
exaly  

Lamivudine

Reactions Weekly, 2019
openaire   +2 more sources

Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

Lancet, The, 1997
exaly  

Lamivudine

Reactions Weekly, 1995
openaire   +1 more source